HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hypersensitivity (Allergy)

Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.
Also Known As:
Allergy; Allergies; Allergic Reaction; Allergic Reactions; Hypersensitivities; Reaction, Allergic; Reactions, Allergic
Networked: 76867 relevant articles (2574 outcomes, 7322 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Asthma (Bronchial Asthma)
2. Hypersensitivity (Allergy)
3. Pain (Aches)
4. Infections
5. Neoplasms (Cancer)

Experts

1. Valenta, Rudolf: 166 articles (10/2022 - 01/2002)
2. Bruze, Magnus: 137 articles (07/2022 - 01/2002)
3. Johansen, Jeanne D: 94 articles (06/2022 - 01/2003)
4. Menné, Torkil: 94 articles (11/2021 - 03/2002)
5. Asero, R: 77 articles (01/2022 - 04/2000)
6. Demoly, Pascal: 77 articles (01/2022 - 03/2003)
7. Vieths, Stefan: 76 articles (01/2022 - 01/2002)
8. Phillips, Elizabeth J: 75 articles (10/2022 - 03/2002)
9. Sampson, Hugh A: 73 articles (01/2022 - 06/2002)
10. Jensen-Jarolim, Erika: 72 articles (10/2022 - 09/2003)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Hypersensitivity:
1. AllergensIBA
2. Immunoglobulin E (IgE)IBA
3. Penicillins (Penicillin)FDA Link
4. AntigensIBA
5. Anti-Bacterial Agents (Antibiotics)IBA
6. VaccinesIBA
7. Proteins (Proteins, Gene)FDA Link
8. AntibodiesIBA
9. Arthropod VenomsIBA
10. Adrenal Cortex Hormones (Corticosteroids)IBA

Therapies and Procedures

1. Immunotherapy
2. Therapeutics
3. Drug Therapy (Chemotherapy)
4. Injections
01/01/1990 - "When IFN-gamma injections were given during the contact allergic reaction there was no significant reduction of ear swelling until 72 h (p less than 0.01). "
11/01/2001 - "A major potential benefit provided by MPL adjuvant is the promotion of a Th1 response which enhances the efficacy of allergy vaccination and can consequently allow a reduction in the number of injections required for treatment. "
10/23/2009 - "This was the background to develop non injections routes for SIT and particularly sublingual immunotherapy (SLIT), that emerged as a real treatment option for respiratory allergy.A number of studies was conducted to evaluate efficacy and safety of SLIT, the first meta-analysis - including 22 placebo-controlled trials - concluded for positive results in both issues, but the number of studies on children was too low to draw definite conclusions. "
01/01/2021 - "The authors tried to summarize the characteristics of the hypersensitivity caused by cosmetic injections and helped to improve the diagnosis and treatment. "
06/01/2004 - "There are a variety of prevention strategies that could be implemented to reduce or eliminate this risk, such as improved nurse training in the administration of allergy injections and compliance with the recommendations in the "Allergen Immunotherapy: A Practice Parameter" for use of patient-specific vials, standardized dosage sheets, and implementation of triple-checking of identity to make sure the correct patient is receiving the correct injection."
5. Premedication